Poseida Therapeutics, Inc.

Historical 13F Holders

Symbol
PSTX
CUSIP
73730P108
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 73730P108 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
FMR LLC 13G/A
0% 2/7/2025
Event 1/31/2025
Malin Life Sciences Holdings Ltd 13G/A
0% 1/15/2025
Event 1/8/2025
Nomura Holdings Inc 13G/A
0% 5/15/2025
Event 3/31/2025
Pentwater Capital Management LP 13D/A
0% 1/13/2025
Event 1/8/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2025 Q1 2 100 k $308k
2024 Q4 119 54.1 M $519M
2024 Q3 99 53.6 M $153M
2024 Q2 95 53.2 M $155M
2024 Q1 92 52.9 M $169M
2023 Q4 92 45.3 M $152M
2023 Q3 87 45.2 M $108M
2023 Q2 95 44.5 M $78.4M
2023 Q1 103 44.1 M $136M
2022 Q4 92 43.0 M $228M
2022 Q3 69 40.1 M $142M
2022 Q2 57 22.5 M $58.1M
2022 Q1 65 24.2 M $108M
2021 Q4 67 26.2 M $178M
2021 Q3 69 26.2 M $191M
2021 Q2 74 27.9 M $279M
2021 Q1 63 28.9 M $276M
2020 Q4 57 26.3 M $288M
2020 Q3 53 25.4 M $217M